Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 10.673 Q1 | 254 | 36 | 74 | 12166 | 1847 | 74 | 25.95 | 337.94 | |
2 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.120 Q1 | 82 | 12 | 34 | 2387 | 151 | 34 | 3.36 | 198.92 | |
3 | Advances in Molecular Toxicology | book series | 0.442 Q3 | 18 | 8 | 23 | 1491 | 36 | 13 | 1.60 | 186.38 | |
4 | Reviews of Physiology Biochemistry and Pharmacology | journal | 70 | 10 | 0 | 1845 | 0 | 0 | 0.00 | 184.50 | ||
5 | Pharmacology and Therapeutics | journal | 3.668 Q1 | 233 | 108 | 306 | 19821 | 3151 | 302 | 9.47 | 183.53 | |
6 | Medicinal Research Reviews | journal | 2.488 Q1 | 150 | 38 | 76 | 6847 | 646 | 74 | 7.59 | 180.18 | |
7 | Food and Drug Law Journal | journal | 0.173 Q4 | 23 | 23 | 92 | 4024 | 39 | 91 | 0.28 | 174.96 | |
8 | Frontiers in Medicinal Chemistry | book series | 0.231 Q3 | 7 | 17 | 44 | 2779 | 16 | 42 | 0.00 | 163.47 | |
9 | Drug Metabolism Reviews | journal | 1.556 Q1 | 108 | 18 | 103 | 2906 | 568 | 99 | 5.25 | 161.44 | |
10 | Advances in Pharmacology | journal | 2.207 Q1 | 86 | 34 | 86 | 5270 | 423 | 10 | 5.35 | 155.00 | |
11 | Natural Product Reports | journal | 3.623 Q1 | 211 | 72 | 242 | 10736 | 2497 | 233 | 9.99 | 149.11 | |
12 | Critical Reviews in Toxicology | journal | 2.025 Q1 | 129 | 42 | 117 | 5856 | 849 | 112 | 7.27 | 139.43 | |
13 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 7 | 23 | 956 | 2 | 23 | 0.05 | 136.57 | ||
14 | Advanced Drug Delivery Reviews | journal | 4.499 Q1 | 366 | 180 | 380 | 22774 | 5329 | 337 | 13.52 | 126.52 | |
15 | Topics in Medicinal Chemistry | book series | 0.243 Q3 | 15 | 9 | 33 | 1105 | 13 | 25 | 0.26 | 122.78 | |
16 | Drug Resistance Updates | journal | 3.276 Q1 | 132 | 26 | 62 | 3117 | 625 | 60 | 10.17 | 119.88 | |
17 | Annual Review of Pharmacology and Toxicology | journal | 10.673 Q1 | 224 | 26 | 54 | 3020 | 1334 | 54 | 24.89 | 116.15 | |
18 | Handbook of Experimental Pharmacology | journal | 1.613 Q1 | 110 | 152 | 373 | 17166 | 1733 | 345 | 4.03 | 112.93 | |
19 | Current Drug Metabolism | journal | 1.139 Q1 | 122 | 131 | 261 | 14321 | 1311 | 232 | 4.51 | 109.32 | |
20 | Studies in Natural Products Chemistry | book series | 49 | 40 | 0 | 4190 | 0 | 0 | 0.00 | 104.75 | ||
21 | Cellular and Molecular Life Sciences | journal | 3.403 Q1 | 261 | 293 | 899 | 30443 | 6406 | 889 | 6.46 | 103.90 | |
22 | Progress in Medicinal Chemistry | journal | 1.110 Q1 | 38 | 5 | 26 | 518 | 58 | 12 | 2.25 | 103.60 | |
23 | Drugs in Context | journal | 36 | 3 | 0 | 310 | 0 | 0 | 0.00 | 103.33 | ||
24 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.336 Q3 | 50 | 43 | 127 | 4408 | 132 | 119 | 1.04 | 102.51 | |
25 | Expert Opinion on Emerging Drugs | journal | 0.898 Q2 | 54 | 44 | 137 | 4301 | 471 | 137 | 3.09 | 97.75 | |
26 | Journal of Experimental Pharmacology | journal | 0.121 Q4 | 23 | 2 | 1 | 192 | 0 | 1 | 0.00 | 96.00 | |
27 | Expert Opinion on Drug Discovery | journal | 0.782 Q2 | 84 | 90 | 274 | 8586 | 627 | 273 | 2.42 | 95.40 | |
28 | Neurotherapeutics | journal | 2.526 Q1 | 136 | 67 | 196 | 6383 | 1363 | 182 | 6.98 | 95.27 | |
29 | Issues in Toxicology | book series | 0.195 Q3 | 18 | 72 | 68 | 6768 | 52 | 64 | 0.72 | 94.00 | |
30 | Current Pharmaceutical Biotechnology | journal | 1.008 Q1 | 97 | 269 | 421 | 24520 | 1344 | 384 | 2.83 | 91.15 | |
31 | Expert Opinion on Drug Delivery | journal | 1.895 Q1 | 133 | 118 | 308 | 10235 | 1925 | 306 | 5.80 | 86.74 | |
32 | Frontiers in Pharmacology | journal | 0.717 Q2 | 154 | 206 | 129 | 17703 | 312 | 125 | 2.42 | 85.94 | |
33 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.942 Q2 | 100 | 127 | 366 | 10730 | 1396 | 363 | 3.62 | 84.49 | |
34 | Milestones in Drug Therapy | book series | 0.110 Q4 | 6 | 49 | 59 | 4127 | 7 | 58 | 0.12 | 84.22 | |
35 | Pharmacogenomics and Personalized Medicine | journal | 0.150 Q4 | 37 | 11 | 31 | 914 | 13 | 31 | 0.55 | 83.09 | |
36 | Expert Opinion on Therapeutic Targets | journal | 1.788 Q1 | 106 | 138 | 337 | 11271 | 1536 | 335 | 4.36 | 81.67 | |
37 | Journal of International Peacekeeping | journal | 0.138 Q4 | 14 | 15 | 50 | 1222 | 21 | 47 | 0.34 | 81.47 | |
38 | Antibodies | journal | 42 | 17 | 0 | 1370 | 0 | 0 | 0.00 | 80.59 | ||
39 | Open Pharmacology Journal | journal | 0.201 Q3 | 6 | 5 | 10 | 400 | 11 | 10 | 1.80 | 80.00 | |
40 | Open Neuropsychopharmacology Journal | journal | 0.183 Q3 | 6 | 3 | 20 | 238 | 11 | 19 | 0.38 | 79.33 | |
41 | Expert Opinion on Therapeutic Patents | journal | 1.330 Q1 | 88 | 100 | 339 | 7922 | 1229 | 333 | 3.47 | 79.22 | |
42 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.394 Q3 | 30 | 27 | 81 | 2124 | 126 | 80 | 1.75 | 78.67 | |
43 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.515 Q1 | 99 | 23 | 76 | 1791 | 447 | 75 | 4.75 | 77.87 | |
44 | Expert Opinion on Investigational Drugs | journal | 1.486 Q1 | 117 | 161 | 456 | 12444 | 2063 | 446 | 4.32 | 77.29 | |
45 | Neuropharmacology | journal | 2.315 Q1 | 191 | 408 | 798 | 31474 | 4103 | 782 | 4.39 | 77.14 | |
46 | Clinical Pharmacokinetics | journal | 2.254 Q1 | 184 | 56 | 179 | 4291 | 1219 | 160 | 7.01 | 76.63 | |
47 | Pharmaceuticals | journal | 0.539 Q2 | 87 | 78 | 297 | 5945 | 500 | 293 | 1.70 | 76.22 | |
48 | Side Effects of Drugs Annual | book series | 0.102 Q4 | 9 | 53 | 157 | 4034 | 4 | 53 | 0.02 | 76.11 | |
49 | Neurotoxicity Research | journal | 1.217 Q1 | 84 | 68 | 245 | 5163 | 870 | 241 | 3.23 | 75.93 | |
50 | Toxin Reviews | journal | 0.328 Q3 | 54 | 7 | 56 | 531 | 72 | 54 | 1.00 | 75.86 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®